PropThink: DCTH Declines After CHEMOSAT Receives Standard Review

[ACN Newswire] – By Jake KingAfter much anticipation over the last few weeks, Delcath Systems (NASDAQ:DCTH) announced Monday that the New Drug Application for its CHEMOSAT hepatic chemosaturation system has been accepted … more

View todays social media effects on DCTH

View the latest stocks trending across Twitter. Click to view dashboard